[
    [
        {
            "time": "",
            "original_text": "申请获FDA受理，国产PD-1海外竞争第二赛点来临！",
            "features": {
                "keywords": [
                    "FDA",
                    "国产PD-1",
                    "海外竞争",
                    "赛点"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "申请获FDA受理，国产PD-1海外竞争第二赛点来临！",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "北向资金 | 合计净流出5.27亿元，三一重工、东方财富、恒瑞医药、五粮液净卖出居前",
            "features": {
                "keywords": [
                    "北向资金",
                    "净流出",
                    "三一重工",
                    "东方财富",
                    "恒瑞医药",
                    "五粮液"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "金融",
                    "医药",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "北向资金 | 合计净流出5.27亿元，三一重工、东方财富、恒瑞医药、五粮液净卖出居前",
                "Correlation": 8,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "推动中国医疗机构的科研发展——恒瑞医药与施普林格·自然举行战略合作签约",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "科研发展",
                    "战略合作"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "推动中国医疗机构的科研发展——恒瑞医药与施普林格·自然举行战略合作签约",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "北向资金本周净买入额创纪录，美的集团获大幅净买入逾11亿元",
            "features": {
                "keywords": [
                    "北向资金",
                    "净买入",
                    "美的集团"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "家电"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "北向资金本周净买入额创纪录，美的集团获大幅净买入逾11亿元",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "研发费用侵蚀利润？科伦药业净利润波动走低 资产负债率56%",
            "features": {
                "keywords": [
                    "研发费用",
                    "利润",
                    "科伦药业",
                    "资产负债率"
                ],
                "sentiment_score": -0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "研发费用侵蚀利润？科伦药业净利润波动走低 资产负债率56%",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【医药】恒瑞医药入选5项口头报告，抗肿瘤创新梯队稳步推进——2021年ASCO数据系列点评之一（林小伟/王明瑞）",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "抗肿瘤",
                    "创新梯队",
                    "ASCO数据"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药】恒瑞医药入选5项口头报告，抗肿瘤创新梯队稳步推进——2021年ASCO数据系列点评之一（林小伟/王明瑞）",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 6,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "5月27日",
            "original_text": "A股融资融券日报：两融余额增加73.28亿元（5月27日）",
            "features": {
                "keywords": [
                    "两融余额",
                    "A股",
                    "融资融券"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "A股融资融券日报：两融余额增加73.28亿元（5月27日）",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "恒瑞医药张连山：医药发展从“模仿创新”到“原始创新”的必经之路",
            "features": {
                "keywords": [
                    "恒瑞医药",
                    "模仿创新",
                    "原始创新"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "恒瑞医药张连山：医药发展从“模仿创新”到“原始创新”的必经之路",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "身家均超千亿，孙飘扬、钟慧娟这对“民企最强夫妻”的成功之道",
            "features": {
                "keywords": [
                    "孙飘扬",
                    "钟慧娟",
                    "民企",
                    "成功之道"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "false",
                "causal_impact": "",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "身家均超千亿，孙飘扬、钟慧娟这对“民企最强夫妻”的成功之道",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 4,
                "Entity_Density": 7,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "4000点要来了？外资加速扫货，茅台等5股被买爆",
            "features": {
                "keywords": [
                    "4000点",
                    "外资",
                    "茅台"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "市场整体",
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "4000点要来了？外资加速扫货，茅台等5股被买爆",
                "Correlation": 7,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "百济神州大幅扩张销售团队 新药研发竞速又遭遇劳动纠纷",
            "features": {
                "keywords": [
                    "百济神州",
                    "销售团队",
                    "新药研发",
                    "劳动纠纷"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "百济神州大幅扩张销售团队 新药研发竞速又遭遇劳动纠纷",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]